Skip to main content

Table 3 Long-term adverse events in 124 infusions

From: Real world safety of CT-P10 (anti-CD 20 monoclonal antibodies biosimilar) in rheumatic and autoimmune diseases

Events

Number of events (%)

Total

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

Infection (N = 35 events)

      

 Bacteria

14 (11.3)

1 (0.8)

2 (1.6)

8 (6)

1 (0.8)

2 (1.6)

 Pseudomonas spp. septicemia

4 (3.2)

0 (0.0)

0 (0.0)

2 (1.6)

1 (0.8)

1 (0.8)

 E.coli septicemia

3 (2.4)

0 (0.0)

0 (0.0)

2 (1.6)

0 (0.0)

1 (0.8)

 Bacterial infection/diarrhea

4 (3.2)

1 (0.8)

2 (1.6)

1 (0.8)

0 (0.0)

0 (0.0)

 Acute bacterial cholangitis

2 (1.6)

0 (0.0)

0 (0.0)

2 (1.6)

0 (0.0)

0 (0.0)

 Gram negative septicemia

1 (0.8)

0 (0.0)

0 (0.0)

1 (0.8)

0 (0.0)

0 (0.0)

 Virus

15 (12.1)

13 (10.5)

0 (0.0)

2 (1.6)

0 (0.0)

0 (0.0)

 URI

10 (8.1)

10 (8.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Viral gastroenteritis

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Varicella

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Herpes viral infection

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 CMV infection

2 (1.6)

0 (0.0)

0 (0.0)

2 (1.6)

0 (0.0)

0 (0.0)

 Fungus

6 (4.8)

0 (0.0)

1 (0.8)

3 (2.4)

2 (1.6)

0 (0.0)

 Pneumonia

3 (2.4)

0 (0.0)

0 (0.0)

3 (2.4)

0 (0.0)

0 (0.0)

 IPA with LUL aneurysm rupture

2 (1.6)

0 (0.0)

0 (0.0)

0 (0.0)

2 (1.6)

0 (0.0)

 Cutaneous candidiasis

1 (0.8)

0 (0.0)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

 Mycobacteria

2 (1.6)

0 (0.0)

0 (0.0)

2 (1.6)

0 (0.0)

0 (0.0)

Hematologic (N = 33 events)

      

 Anemia

5 (4.0)

2 (1.6)

2 (1.6)

1 (0.8)

0 (0.0)

0 (0.0)

 Neutropenia

10 (8.1)

0 (0.0)

6 (4.8)

4 (3.2)

0 (0.0)

0 (0.0)

 Lymphopenia

15 (12.1)

8 (6.5)

7 (6.5)

0 (0.0)

0 (0.0)

0 (0.0)

 Thrombocytopenia

3 (2.4)

1 (0.8)

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

 Chylous ascites (N = 1 event)

1 (0.8)

0 (0.0)

0 (0.0)

1 (0.8)

0 (0.0)

0 (0.0)

Others (N = 10 events)

      

 Transaminitis

6 (4.8)

6 (4.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Respiratory failure

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Muscle pain

1 (0.8)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Fatigue

1 (0.8)

0 (0.0)

1 (0.8)

0 (0.0)

0 (0.0)

0 (0.0)

 Nausea/Vomiting

1 (0.8)

0 (0.0)

0 (0.0)

1 (0.8)

0 (0.0)

0 (0.0)

  1. URI, upper respiratory tract viral infection; CMV, cytomegalovirus; IPA, invasive pulmonary aspergillosis; LUL, left upper lung aneurysm